• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Trop2 是促进人类乳腺癌 EMT 的潜在生物标志物。

Trop2 is a potential biomarker for the promotion of EMT in human breast cancer.

机构信息

Department of Pathology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu 210006, P.R. China.

Department of Pathology, Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China.

出版信息

Oncol Rep. 2018 Aug;40(2):759-766. doi: 10.3892/or.2018.6496. Epub 2018 Jun 14.

DOI:10.3892/or.2018.6496
PMID:29901160
Abstract

Trop2 is considered to have an important function in tumor metastasis and the promotion of epithelial‑mesenchymal transition (EMT). E‑cadherin is a crucial factor in intercellular adhesion and EMT transformation. In the present study, we detected the expression of Trop2 and E‑cadherin in breast cancer (BC) to better define their prognostic value. The mRNA expression levels of these two genes in 20 cases of fresh BC tissues were detected by quantitative real‑time polymerase chain reaction (qRT‑PCR). We also detected the expression levels of these two genes by immunohistochemistry (IHC) in 312 BC tissues, and the correlations between the expression of these two genes and the clinicopathological characteristics in BC patients were analyzed. The mRNA and protein expression levels of the two genes in BC cell lines were studied by qRT‑PCR and western blotting. The results indicated that Trop2+/E‑cadherin‑ was expressed in BC tissues more than that in the matched adjacent tissues. The protein expression results obtained via IHC were similar to the mRNA expression results. Trop2+/E‑cadherin‑ that was expressed in BC was associated with lymph node status, metastasis, tumor‑node‑metastasis (TNM) stage, and ER‑/PR‑/HER2‑ expression. BC patients that expressed Trop2+/E‑cadherin‑ had poor overall survival rates. The results of Trop2 and E‑cadherin expression levels obtained in the BC cell lines were the same as those obtained in the BC tissues. Overall, Trop2 has a potential role in the promotion of EMT in BC and it could be considered as a therapeutic target in the future.

摘要

Trop2 被认为在肿瘤转移和上皮-间质转化(EMT)的促进中具有重要功能。E-钙黏蛋白是细胞间黏附的关键因素,也是 EMT 转化的关键因素。在本研究中,我们检测了乳腺癌(BC)中 Trop2 和 E-钙黏蛋白的表达,以更好地定义它们的预后价值。通过实时定量聚合酶链反应(qRT-PCR)检测 20 例新鲜 BC 组织中这两个基因的 mRNA 表达水平。我们还通过免疫组织化学(IHC)检测了 312 例 BC 组织中这两个基因的表达水平,并分析了这两个基因的表达与 BC 患者临床病理特征之间的相关性。通过 qRT-PCR 和 Western blot 研究了这两个基因在 BC 细胞系中的 mRNA 和蛋白表达水平。结果表明,Trop2+/E-钙黏蛋白-在 BC 组织中的表达高于配对的相邻组织。IHC 获得的蛋白表达结果与 mRNA 表达结果相似。在 BC 中表达的 Trop2+/E-钙黏蛋白-与淋巴结状态、转移、肿瘤-淋巴结-转移(TNM)分期和 ER-/PR-/HER2-表达有关。表达 Trop2+/E-钙黏蛋白-的 BC 患者总生存率较差。BC 细胞系中 Trop2 和 E-钙黏蛋白表达水平的结果与 BC 组织中的结果相同。总之,Trop2 在促进 BC 中的 EMT 中具有潜在作用,将来可能被视为一种治疗靶点。

相似文献

1
Trop2 is a potential biomarker for the promotion of EMT in human breast cancer.Trop2 是促进人类乳腺癌 EMT 的潜在生物标志物。
Oncol Rep. 2018 Aug;40(2):759-766. doi: 10.3892/or.2018.6496. Epub 2018 Jun 14.
2
The role and molecular mechanism of Trop2 induced epithelial-mesenchymal transition through mediated β-catenin in gastric cancer.Trop2 通过介导β-catenin 诱导胃癌上皮-间充质转化的作用和分子机制。
Cancer Med. 2019 Mar;8(3):1135-1147. doi: 10.1002/cam4.1934. Epub 2019 Jan 11.
3
Overexpression of trophoblast cell surface antigen 2 as an independent marker for a poor prognosis and as a potential therapeutic target in epithelial ovarian carcinoma.滋养层细胞表面抗原2的过表达作为上皮性卵巢癌预后不良的独立标志物及潜在治疗靶点。
Int J Exp Pathol. 2016 Apr;97(2):150-8. doi: 10.1111/iep.12174. Epub 2016 Apr 29.
4
Expression of interleukin-6 is associated with epithelial-mesenchymal transition and survival rates in gallbladder cancer.白细胞介素-6的表达与胆囊癌的上皮-间质转化及生存率相关。
Mol Med Rep. 2015 May;11(5):3539-46. doi: 10.3892/mmr.2014.3143. Epub 2014 Dec 31.
5
LAPTM4B Predicts Axillary Lymph Node Metastasis in Breast Cancer and Promotes Breast Cancer Cell Aggressiveness in Vitro.LAPTM4B预测乳腺癌腋窝淋巴结转移并在体外促进乳腺癌细胞侵袭性。
Cell Physiol Biochem. 2017;41(3):1072-1082. doi: 10.1159/000464115. Epub 2017 Feb 27.
6
TROP2 promotes proliferation, migration and metastasis of gallbladder cancer cells by regulating PI3K/AKT pathway and inducing EMT.TROP2通过调节PI3K/AKT信号通路和诱导上皮-间质转化促进胆囊癌细胞的增殖、迁移和转移。
Oncotarget. 2017 Jul 18;8(29):47052-47063. doi: 10.18632/oncotarget.16789.
7
Trop2 is overexpressed in gastric cancer and predicts poor prognosis.Trop2在胃癌中过表达,并预示预后不良。
Oncotarget. 2016 Feb 2;7(5):6136-45. doi: 10.18632/oncotarget.6733.
8
Correlation between Trop2 and amphiregulin coexpression and overall survival in gastric cancer.Trop2与双调蛋白共表达与胃癌总生存期的相关性
Cancer Med. 2017 May;6(5):994-1001. doi: 10.1002/cam4.1018. Epub 2017 Mar 3.
9
E‑cadherin is downregulated by microenvironmental changes in pancreatic cancer and induces EMT.E-钙黏蛋白在胰腺癌的微环境变化中下调,并诱导 EMT。
Oncol Rep. 2018 Sep;40(3):1641-1649. doi: 10.3892/or.2018.6528. Epub 2018 Jun 27.
10
SKA2 mediates invasion and metastasis in human breast cancer via EMT.SKA2 通过 EMT 介导人乳腺癌的侵袭和转移。
Mol Med Rep. 2019 Jan;19(1):515-523. doi: 10.3892/mmr.2018.9623. Epub 2018 Nov 2.

引用本文的文献

1
Inter-Assay Variability of TROP2 Immunohistochemistry in Triple-Negative Breast Cancer.三阴性乳腺癌中TROP2免疫组织化学检测的批间差异
Mol Diagn Ther. 2025 Sep 6. doi: 10.1007/s40291-025-00814-5.
2
Correlation of TROP2 expression with clinico-pathological features and outcomes in HR+/HER2- breast cancer receiving neoadjuvant chemotherapy.TROP2表达与接受新辅助化疗的HR+/HER2-乳腺癌临床病理特征及预后的相关性
Oncologist. 2025 Jul 4;30(7). doi: 10.1093/oncolo/oyaf184.
3
stClinic dissects clinically relevant niches by integrating spatial multi-slice multi-omics data in dynamic graphs.
stClinic通过在动态图中整合空间多层多组学数据来剖析临床相关生态位。
Nat Commun. 2025 Jun 16;16(1):5317. doi: 10.1038/s41467-025-60575-x.
4
The underlying difference of metastatic and non-metastatic breast cancer cells in configuring type I collagen fibres to promote migration by cell mechanics.转移性和非转移性乳腺癌细胞在通过细胞力学构建I型胶原纤维以促进迁移方面的潜在差异。
Mechanobiol Med. 2025 Jan 31;3(2):100113. doi: 10.1016/j.mbm.2025.100113. eCollection 2025 Jun.
5
The search for a TNBC vaccine: the guardian vaccine.三阴性乳腺癌疫苗的探索:守护者疫苗。
Cancer Biol Ther. 2025 Dec;26(1):2472432. doi: 10.1080/15384047.2025.2472432. Epub 2025 Mar 15.
6
Prognostic Value of Trop-2 Expression in Nonmetastatic Triple-Negative Breast Cancer and Correlation With Emerging Biomarkers.Trop-2表达在非转移性三阴性乳腺癌中的预后价值及其与新兴生物标志物的相关性
Cancer Med. 2025 Mar;14(5):e70615. doi: 10.1002/cam4.70615.
7
Advances in antibody-drug conjugates in the treatment of advanced triple-negative breast cancer: a narrative review.抗体药物偶联物在晚期三阴性乳腺癌治疗中的进展:一项叙述性综述。
Transl Breast Cancer Res. 2025 Jan 21;6:9. doi: 10.21037/tbcr-24-38. eCollection 2025.
8
Immunoconjugates as an Efficient Platform for Drug Delivery: A Resurgence of Natural Products in Targeted Antitumor Therapy.免疫偶联物作为一种高效的药物递送平台:天然产物在靶向抗肿瘤治疗中的复兴。
Pharmaceuticals (Basel). 2024 Dec 17;17(12):1701. doi: 10.3390/ph17121701.
9
Programming tissue-sensing T cells that deliver therapies to the brain.对可向大脑输送治疗的组织感知T细胞进行编程。
Science. 2024 Dec 6;386(6726):eadl4237. doi: 10.1126/science.adl4237.
10
Advances in Trop-2 targeted antibody-drug conjugates for breast cancer: mechanisms, clinical applications, and future directions. Trop-2 靶向抗体药物偶联物在乳腺癌中的研究进展:作用机制、临床应用及未来方向。
Front Immunol. 2024 Nov 1;15:1495675. doi: 10.3389/fimmu.2024.1495675. eCollection 2024.